Reardon, D., Schuster, J., Tran, D., Fink, K., Nabors, L., Li, G., … Sampson, J. (2014). IT-30 * ReACT: A PHASE II STUDY OF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA. Neuro-Oncology, 16(suppl 5), v116–v116. https://doi.org/10.1093/neuonc/nou258.28

Reardon, D., J. Schuster, D. Tran, K. Fink, L. Nabors, G. Li, R. Lukas, et al. “IT-30 * ReACT: A PHASE II STUDY OF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA.” Neuro-Oncology 16, no. suppl 5 (November 1, 2014): v116–v116. https://doi.org/10.1093/neuonc/nou258.28.

Reardon D, Schuster J, Tran D, Fink K, Nabors L, Li G, et al. IT-30 * ReACT: A PHASE II STUDY OF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA. Neuro-Oncology. 2014 Nov 1;16(suppl 5):v116–v116.

Reardon, D., et al. “IT-30 * ReACT: A PHASE II STUDY OF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA.” Neuro-Oncology, vol. 16, no. suppl 5, Oxford University Press (OUP), Nov. 2014, pp. v116–v116. Crossref, doi:10.1093/neuonc/nou258.28.

Reardon D, Schuster J, Tran D, Fink K, Nabors L, Li G, Lukas R, Desjardins A, Ashby L, Duic JP, Aneiro L, Hawthorne T, Green J, Yellin M, Davis T, Sampson J. IT-30 * ReACT: A PHASE II STUDY OF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA. Neuro-Oncology. Oxford University Press (OUP); 2014 Nov 1;16(suppl 5):v116–v116.